Program to evaluate the Tasigna (nilotinib) educational materials: survey to patients and physicians in five EU countries

First published 13/03/2014

Last updated 01/04/2024

EU PAS number:

EUPAS6073

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

AMN107A2001--protocol_Redacted

English (1.46 MB - PDF)View document

Study results

Study results

CAMN107A2001 CSR EuPAS6073_Redacted

English (2.95 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents